Table 2.
First author (year) | Location | Study design | Health status | Gender | Sample size | Duration (week) | Mean age (year) | Baseline BMI (kg/m2) | Intervention | Outcome | |
---|---|---|---|---|---|---|---|---|---|---|---|
Treatment group | Control group | ||||||||||
Cesara (2010) (a) | Brazil | Randomised, placebo-controlled, parallel trial | hypercholesterolaemic | Both | 22 | 8 | 43·15 | 26 | 750 ml orange juice | Placebo | TC/TG/LDL/HDL |
Cesara (2010) (b) | Brazil | Randomised, placebo-controlled, parallel trial | Normorcholesterolaemic | Both | 39 | 8 | 39·9 | 27·2 | 750 ml orange juice | Placebo | TC/TG/LDL/HDL |
Aptekmann (2010) | Brazil | Randomised, placebo-controlled, parallel trial | Overweight | Female | 26 | 12 | 39 | 28·7 | 500 ml orange juice | Placebo | TC/TG/LDL/HDL |
Morand (2010) | France | Randomised, double-blind, placebo-controlled, cross-over | Overweight | Male | 24 | 4 | 56 | 27·4 | 500 ml orange juice | Placebo | TC/TG/LDL/HDL |
Asgary (2014) | Iran | Randomised, single-blind, placebo-controlled, cross-over | Healthy | Both | 21 | 4 | 35·13 | 24·5 | 1000 ml orange juice | Placebo | TC/TG/LDL/HDL |
Constans (2014) | France | Randomised, single-blind, placebo-controlled, cross-over | Hypercholesterolaemic | Male | 25 | 3 | 53·8 | 26 | 600 ml orange juice | Placebo | TC/TG/LDL/HDL |
Simpson (2016) | UK | Randomised, single-blind, placebo-controlled, parallel trial | Overweight | Male | 36 | 12 | 48·3 | 31 | 250 ml orange juice | Placebo | TC/TG/LDL/HDL |
Ribeiro (2016) | Brazil | Randomised, non-blind, placebo-controlled, parallel trial | Obese | Both | 78 | 12 | 36 | 33 | 500 ml orange juice and reduced-calorie diet | Reduced-calorie diet | TC/TG/LDL/HDL |
Gonçalves (2017) | Brazil | Randomised, placebo-controlled, parallel trial | Patients with hepatitis C | Both | 43 | 8 | 18< | 23·9 | 500 ml orange juice | Placebo | TC/TG/LDL/HDL |
Ponce (2019) | Brazil | Randomised, non-blind, placebo-controlled, parallel trial | MetS | Both | 72 | 12 | 48 | 34·6 | 500 ml orange juice and nutritional guidance | Placebo and nutritional guidance | TC/TG/LDL/HDL |
TC, total cholesterol; LDL, low-density lipoprotein; HDL, high-density lipoprotein; TG, triglycerides; MetS, metabolic syndrome.